Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05629546
Title Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.